- Home
- DUK vs GSK Comparison
DUK vs GSK Comparison
Compare DUK & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUK
- GSK
- Stock Information
- Founded
- DUK 1904
- GSK 1715
- Country
- DUK United States
- GSK United Kingdom
- Employees
- DUK N/A
- GSK N/A
- Industry
- DUK Railroads
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- DUK Industrials
- GSK Health Care
- Exchange
- DUK Nasdaq
- GSK Nasdaq
- Market Cap
- DUK 89.7B
- GSK 86.1B
- IPO Year
- DUK N/A
- GSK N/A
- Fundamental
- Price
- DUK $118.73
- GSK $38.99
- Analyst Decision
- DUK Buy
- GSK Hold
- Analyst Count
- DUK 17
- GSK 3
- Target Price
- DUK $127.67
- GSK N/A
- AVG Volume (30 Days)
- DUK 2.8M
- GSK 5.1M
- Earning Date
- DUK 08-05-2025
- GSK 07-30-2025
- Dividend Yield
- DUK 3.52%
- GSK 4.05%
- EPS Growth
- DUK 51.35
- GSK N/A
- EPS
- DUK 6.02
- GSK 0.98
- Revenue
- DUK $30,512,000,000.00
- GSK $40,735,668,430.00
- Revenue This Year
- DUK $7.08
- GSK $6.70
- Revenue Next Year
- DUK $3.65
- GSK $5.42
- P/E Ratio
- DUK $19.75
- GSK $19.24
- Revenue Growth
- DUK 5.22
- GSK 2.57
- 52 Week Low
- DUK $99.21
- GSK $31.72
- 52 Week High
- DUK $125.27
- GSK $44.67
- Technical
- Relative Strength Index (RSI)
- DUK 58.10
- GSK 44.08
- Support Level
- DUK $115.35
- GSK $38.22
- Resistance Level
- DUK $117.96
- GSK $38.84
- Average True Range (ATR)
- DUK 1.57
- GSK 0.59
- MACD
- DUK 0.35
- GSK -0.28
- Stochastic Oscillator
- DUK 85.70
- GSK 14.05
About DUK Duke Energy Corporation (Holding Company)
Duke Energy is one of the largest US utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to more than 8 million customers. Its natural gas utilities serve more than 1.6 million customers.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.